Separation Anxiety…Begone: Advances in Biomolecule Analysis from Peptides to Antibody-Drug Conjugates
Webinar
Biotherapeutics are becoming a dominant force in the medical practitioner toolbox. A myriad of pharmaceutical companies are developing new therapeutics to treat a plethora of diseases, and many of these drugs are proteinaceous in nature. As the demand for biotherapeutics increases, the need for robust, reproducible, and efficient methods for characterizing the drug is of paramount importance.
During the webinar, you will:
- Discover how liquid chromatography is applied to characterize biotherapeutics across peptides, proteins, oligonucleotides, antibodies, and antibody-drug conjugates (ADCs).
- Understand modern LC-based techniques and workflows for robust, reproducible biotherapeutic characterization.
- Explore real-world application examples that you can apply directly in your analytical lab.
- Learn best practices for integrating LC methods into quality control and development pipelines to improve efficiency and reliability.
Speakers

Cory E. Muraco
Senior Global Product Manager, Large Molecule HPLC Columns
Cory E. Muraco is the Senior Global Product Manager for Large Molecule HPLC Columns at MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany. After finishing his graduate studies at Youngstown State University (Youngstown, Ohio, USA), Cory started his career at MilliporeSigma in 2013. After holding several roles in both R&D and Marketing functions across the past decade, in 2026, Cory assumed his current role as the Large Molecule HPLC Columns Product Manager where he is tasked with designing, developing, and executing the marketing and R&D strategies around MilliporeSigma’s biomolecule HPLC columns. Cory is the author of several manuscripts appearing in trade magazines and has delivered over 100 presentations at international conferences, round table symposia, and at various pharmaceutical and biopharmaceutical companies.
Analytical chemistry
- Analytical chemistry
Duration:1h
Language:English
Session 1:Wed, October 14, 2026 11:00 AM CEST